Icecure Medical (ICCM) Stock Price

Icecure Medical Price

NASDAQ·CLOSED
1.09
​
Market closed

Over the last 11 years Icecure Medical grew revenue by 22.9% annually, reaching 3.29 M USD. For Icecure Medical, the net margin of -465.5% is down versus -96.4% a few years ago. The consensus 12-month price target for Icecure Medical is 3.19 USD, about 192.4% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

Icecure Medical stock price

Access this data via the Eulerpool API

Icecure Medical business model & stock analysis

IceCure Medical Ltd. is a commercial stage medical device company. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.

Frequently asked questions about Icecure Medical

Analysts currently set an average price target of 3.19 USD for the Icecure Medical stock (median: 3.19 USD), implying +192.4 % versus the latest price. The consensus is based on 8 analyst ratings.

9 analysts currently rate the Icecure Medical stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Icecure Medical to generate revenue of 4.30 M USD and earnings per share of -7.25 USD.

Converted at the current exchange rate, the Icecure Medical share trades at 0.98 EUR (1.09 USD).

The Icecure Medical share (ICCM) is listed on 1 stock exchanges, including: NASDAQ (ICCM).

The expected revenue of Icecure Medical is 4.30 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Icecure Medical is -368.94 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Icecure Medical is currently -0.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Icecure Medical stock.

The price-to-sales ratio (P/S) of Icecure Medical is currently 12.91. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Icecure Medical stock.

The Eulerpool Quality Score for Icecure Medical is 3/10.

The ISIN of Icecure Medical is IL0011224156. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Icecure Medical is ICCM. The ticker symbol is used to trade Icecure Medical shares on the stock exchange.

Fair ValueTerminal
0.94 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
50,630.77 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Israel
Currency
USD
Initial public offering
Feb 2, 2011
ISIN
IL0011224156
Cusip
M53071136
Market capitalization
75.17 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
-0.12
P/Ee 2026
-0.15
P/Ee 2027
-0.22
P/Ee 2028
-0.36
P/Ee 2029
2.66
P/Se
16.31
EV/EBIT
—
P/B Ratio
10.89
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-221.97 %
Last updated Oct 13, 2026, 7:36 AM

Icecure Medical Peer Group

Icecure Medical Ticker

NASDAQ · ICCM

Icecure Medical FIGI

ICCM:US · BBG005K17W05ICCM:UA · BBG005K17W14ICCM:UC · BBG005K17W23ICCM:UN · BBG005K17W41ICCM:UP · BBG005K17W50ICCM:UB · BBG005K17W78ICCM:UM · BBG005K17W96ICCM:UX · BBG005K17WB3ICCM:UR · BBG005K17WC2ICCM:PQ · BBG005K17WF9ICCM:UD · BBG005K17WJ5ICCM:UF · BBG005K17WM1

All fundamentals and in-depth analysis of Icecure Medical

Our stock analysis for Icecure Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Icecure Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.